Terms ending in 2037
Roche Sequencing Solutions, Inc.
Every in-force patent on Roche Sequencing Solutions, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,624,393 | Deep Sequencing Profiling of Tumors In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,313,588 | Molded Flow Channel In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,467,899 | Molded Flow Channel In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 12,693,263 | Molded Flow Channel In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 10,472,666 | System and Method for Targeted Depletion of Nucleic Acids In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 11,155,853 | System and Method for Targeted Depletion of Nucleic Acids In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 11,846,281 | Two-Way Pump Selectable Valve and Bypass Waste Channel In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 10,266,813 | Exonuclease Deficient Polymerases In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 10,947,516 | Exonuclease Deficient Polymerases In force · High confidence | Roche Sequencing Solutions, Inc. | In force | High confidence | |
| US 11,718,836 | Exonuclease Deficient Polymerases In force · Medium confidence | Roche Sequencing Solutions, Inc. | In force | Medium confidence | |
| 60 more term ends in 2037 · Pro | |||||
10 of 70 patents shown. Soonest term end first, then patent number.
Pro members see all 70.
69 of these are in force and held by Roche Sequencing Solutions, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.